Volume 26, Number 1—January 2020
Synopsis
Spatial Epidemiologic Trends and Hotspots of Leishmaniasis, Sri Lanka, 2001–2018
Table 1
Cases/100,000 population | 2001 |
2009 |
2018 |
|||||
---|---|---|---|---|---|---|---|---|
No. districts | Population | No. districts | Population | No. districts | Population | |||
0 | 12 | 7,728,455 | 7 | 3,899,690 | 2 | 1,306,933 | ||
<1 | 11 | 10,157,597 | 11 | 11,453,975 | 6 | 6,988,158 | ||
1–10 | 2 | 911,205 | 4 | 2,290,870 | 9 | 6,622,843 | ||
11–50 | 0 | 0 | 3 | 2,194,176 | 4 | 3,862,871 | ||
51–100 | 0 | 0 | 0 | 0 | 3 | 2,211,753 | ||
>100 |
0 |
0 |
0 |
0 |
1 |
639,340 |
||
Total | 25 | 18,797,257 | 25 | 19,838,711 | 25 | 21,631,898 |
*Determined by using cutaneous leishmaniasis incidence rates per district and census data from the government of Sri Lanka (http://www.statistics.gov.lk) from 2001 to project potential incidence rates for 2009 and from 2012 to project incidence rates for 2018.
1These authors were co–principal investigators for this article.
Page created: December 18, 2019
Page updated: December 18, 2019
Page reviewed: December 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.